Patent details

Basic Information

Publication number:

EP2698145

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP131806762

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Pharmaceutical Formulations comprising dapoxetine and a PDE5 inhibitor

French Title of Invention:

Formulations pharmaceutiques comprenant de la dapoxétine et un inhibiteur de la PDE-5.

German Title of Invention:

Pharmazeutische Formulierungen enthaltend Dapoxetin und einen PDE5 Inhibitor

SPC Number:

Dates

Filing date:

16/08/2013

Grant date:

02/12/2020

EP Publication Date:

19/02/2014

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

02/12/2020

EP B1 Publication Date:

02/12/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

16/08/2021

Expiration date:

16/08/2033

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

25/11/2020

 

 

Name:

MONTERO GIDA SANAYI VE TICARET A.S.

Address:

Balabandere Cad. Ilac Sanayi Yolu, No: 14, Istinye, Istanbul 34460, Türkiye (TR)

Inventor

1

Name:

Türkyilmaz, Ali

Address:

Türkiye (TR)

2

Name:

Mutlu, Onur

Address:

Türkiye (TR)

3

Name:

Cifter, Ümit

Address:

Türkiye (TR)

Priority

Priority Number:

201209599

Priority Date:

17/08/2012

Priority Country:

Türkiye (TR)

Classification

IPC classification:

A61P 25/24;

Publication

European Patent Bulletin

Issue number:

202049

Publication date:

02/12/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages